Crescita shareholders approve $0.80 per share acquisition by ClinActiv
Tweet Send to a Friend
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) announced that shareholders voted to approve the acquisition by ClinActiv Holdings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


